Lauxera Growth II
France
Growth
Share
About Lauxera Growth II
Paris and SF-based growth investor backing commercial-stage European healthtech companies expanding into the US. €20M–€50M checks, minority and majority. Anchored by Bpifrance, EIF, Morgan Stanley IM.
Investment Focus
Location / RegionFrance
Funding StageGrowth
Industry Focus
Biotech
Diagnostics
Digital Health
Med Tech
Investor Signals Profile
active
Sweet Spot
FDA-cleared European medtech, US commercial scale, transplant/surgical focus
Unlock Investor Signals
$29/month for full signal access. Cancel anytime.